The July jobs report and another packed schedule of second-quarter corporate earnings results await investors this week, offering a host of potentially market-moving events.
Moderna (NASDAQ: MRNA) is now officially a member of the S&P 500. In this Motley Fool Live video recorded on July 21, 2021, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Moderna's tenure on the S&P 500 index will be short-lived. Let's go over to Moderna, which is now officially, I think today, a member of the S&P 500 Index.
Let's face it -- investing can easily turn into a complicated, fruitless endeavor if you're not careful. The stock market's got a dozen different kinds of players, and each of those participants seem to have their own unique goals.